Aptamer-Modified Magnetic Nanoparticles as Targeted Drug Delivery Systems for Hepatocellular Carcinoma
<b>Background</b>: Hepatocellular carcinoma is associated with high mortality and increasing incidence. Sorafenib, a cornerstone of therapy for advanced hepatocellular carcinoma, presents certain disadvantages, including low bioavailability and poor water solubility. This work describes a new strate...
保存先:
| 主要な著者: | , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2025-10-01
|
| シリーズ: | Pharmaceutics |
| 主題: | |
| オンライン・アクセス: | https://www.mdpi.com/1999-4923/17/10/1292 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
